Cargando…
Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review
The use of inhaled antibiotics was initially almost exclusively confined to patients with cystic fibrosis (CF). However, it has been extended in recent decades to patients with non-CF bronchiectasis or chronic obstructive pulmonary disease who present with chronic bronchial infection by potentially...
Autores principales: | de la Rosa-Carrillo, David, Suárez-Cuartín, Guillermo, Sibila, Oriol, Golpe, Rafael, Girón, Rosa-María, Martínez-García, Miguel-Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219413/ https://www.ncbi.nlm.nih.gov/pubmed/37240682 http://dx.doi.org/10.3390/jcm12103577 |
Ejemplares similares
-
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
por: de la Rosa-Carrillo, David, et al.
Publicado: (2022) -
Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
por: Martínez-García, Miguel Ángel, et al.
Publicado: (2020) -
Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
por: Martinez-García, Miguel Ángel, et al.
Publicado: (2022) -
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis
por: García Clemente, Marta, et al.
Publicado: (2022) -
Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study
por: Wang, Xuejie, et al.
Publicado: (2021)